Vorinostat-An Overview

被引：102

作者：

Bubna, Aditya Kumar ^{[1
]}

机构：

[1] Kedar Hosp, Mugalivakkam Main Rd, Madras 600125, Tamil Nadu, India

来源：

INDIAN JOURNAL OF DERMATOLOGY | 2015年 / 60卷 / 04期

关键词：

Cutaneous T cell lymphoma; histone deacytelase inhibitor; Vorinostat; HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; T-CELL LYMPHOMA; CANCER; SAHA; ANGIOGENESIS; EXPRESSION; THERAPY;

D O I：

10.4103/0019-5154.160511

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Vorinostat is a new drug used in the management of cutaneous T cell lymphoma when the disease persists, gets worse or comes back during or after treatment with other medicines. It is an efficacious and well tolerated drug and has been considered a novel drug in the treatment of this condition. Currently apart from cutaneous T cell lymphoma the role of Vorinostat for other types of cancers is being investigated both as mono-therapy and combination therapy.

引用

页数：4

共 39 条

[1]

[Anonymous], 2007, Med Lett Drugs Ther, V49, P23

[2] Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors [J].

Bali, P ;

Pranpat, M ;

Bradner, J ;

Balasis, M ;

Fiskus, W ;

Guo, F ;

Rocha, K ;

Kumaraswamy, S ;

Boyapalle, S ;

Atadja, P ;

Seto, E ;

Bhalla, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) :26729-26734

[3] Acetylation inactivates the transcriptional repressor BCL6 [J].

Bereshchenko, OR ;

Gu, W ;

Dalla-Favera, R .

NATURE GENETICS, 2002, 32 (04) :606-613

[4] Anticancer activities of histone deacetylase inhibitors [J].

Bolden, Jessica E. ;

Peart, Melissa J. ;

Johnstone, Ricky W. .

NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :769-784

[5]

Butler LM, 2000, CANCER RES, V60, P5165

[6]

Cohen LA, 2002, ANTICANCER RES, V22, P1497

[7]

Desai D, 2003, ANTICANCER RES, V23, P499

[8] Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma, (CTCL) [J].

Duvic, Madeleine ;

Talpur, Rakshandra ;

Ni, Xiao ;

Zhang, Chunlei ;

Hazarika, Parul ;

Kelly, Cecilia ;

Chiao, Judy H. ;

Reilly, John F. ;

Ricker, Justin L. ;

Richon, Victoria M. ;

Frankel, Stanley R. .

BLOOD, 2007, 109 (01) :31-39

[9] Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo [J].

Eyüpoglu, IY ;

Hahnen, E ;

Buslei, R ;

Siebzehnrübl, FA ;

Savaskan, NE ;

Lüders, M ;

Tränkle, C ;

Wick, W ;

Weller, M ;

Fahlbusch, R ;

Blümcke, I .

JOURNAL OF NEUROCHEMISTRY, 2005, 93 (04) :992-999

[10] Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors [J].

Finnin M.S. ;

Donigian J.R. ;

Cohen A. ;

Richon V.M. ;

Rifkind R.A. ;

Marks P.A. ;

Breslow R. ;

Pavletich N.P. .

Nature, 1999, 401 (6749) :188-193

← 1 2 3 4 →